Bank of New York Mellon’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.95M | Buy |
345,928
+1,349
| +0.4% | +$38.8K | ﹤0.01% | 1904 |
|
|
2025
Q1 | $11.6M | Sell |
344,579
-186
| -0.1% | -$6.24K | ﹤0.01% | 1775 |
|
|
2024
Q4 | $17.6M | Buy |
344,765
+32,825
| +11% | +$1.68M | ﹤0.01% | 1641 |
|
|
2024
Q3 | $15.9M | Sell |
311,940
-74,510
| -19% | -$3.81M | ﹤0.01% | 1700 |
|
|
2024
Q2 | $17.3M | Buy |
386,450
+89,972
| +30% | +$4.03M | ﹤0.01% | 1663 |
|
|
2024
Q1 | $13.9M | Sell |
296,478
-33,101
| -10% | -$1.55M | ﹤0.01% | 1782 |
|
|
2023
Q4 | $11.7M | Sell |
329,579
-162,468
| -33% | -$5.78M | ﹤0.01% | 1897 |
|
|
2023
Q3 | $14.6M | Buy |
492,047
+28,629
| +6% | +$851K | ﹤0.01% | 1718 |
|
|
2023
Q2 | $8.35M | Buy |
463,418
+40,629
| +10% | +$732K | ﹤0.01% | 2034 |
|
|
2023
Q1 | $6.79M | Buy |
422,789
+71,030
| +20% | +$1.14M | ﹤0.01% | 2132 |
|
|
2022
Q4 | $6.44M | Buy |
351,759
+10,277
| +3% | +$188K | ﹤0.01% | 2186 |
|
|
2022
Q3 | $6.71M | Buy |
341,482
+10,237
| +3% | +$201K | ﹤0.01% | 2140 |
|
|
2022
Q2 | $6.18M | Buy |
331,245
+14,208
| +4% | +$265K | ﹤0.01% | 2207 |
|
|
2022
Q1 | $6.96M | Sell |
317,037
-5,469
| -2% | -$120K | ﹤0.01% | 2262 |
|
|
2021
Q4 | $9.16M | Buy |
322,506
+20,161
| +7% | +$573K | ﹤0.01% | 2146 |
|
|
2021
Q3 | $6.37M | Buy |
302,345
+10,190
| +3% | +$215K | ﹤0.01% | 2369 |
|
|
2021
Q2 | $5.51M | Buy |
292,155
+5,578
| +2% | +$105K | ﹤0.01% | 2437 |
|
|
2021
Q1 | $4.38M | Buy |
286,577
+13,940
| +5% | +$213K | ﹤0.01% | 2497 |
|
|
2020
Q4 | $3.85M | Buy |
272,637
+95,325
| +54% | +$1.35M | ﹤0.01% | 2485 |
|
|
2020
Q3 | $2.78M | Sell |
177,312
-8,311
| -4% | -$130K | ﹤0.01% | 2491 |
|
|
2020
Q2 | $3.25M | Buy |
185,623
+149,591
| +415% | +$2.62M | ﹤0.01% | 2427 |
|
|
2020
Q1 | $529K | Buy |
36,032
+185
| +0.5% | +$2.72K | ﹤0.01% | 3328 |
|
|
2019
Q4 | $899K | Buy |
35,847
+1,183
| +3% | +$29.7K | ﹤0.01% | 3299 |
|
|
2019
Q3 | $521K | Sell |
34,664
-3,922
| -10% | -$58.9K | ﹤0.01% | 3510 |
|
|
2019
Q2 | $964K | Buy |
38,586
+12,608
| +49% | +$315K | ﹤0.01% | 3233 |
|
|
2019
Q1 | $591K | Buy |
25,978
+2,798
| +12% | +$63.7K | ﹤0.01% | 3470 |
|
|
2018
Q4 | $695K | Buy |
23,180
+7,367
| +47% | +$221K | ﹤0.01% | 3304 |
|
|
2018
Q3 | $453K | Buy |
+15,813
| New | +$453K | ﹤0.01% | 3685 |
|